ASPU: The Quiet Ed-Tech Turnaround No One Is Talking About

Aspen Group, Inc. (OTCQB: ASPU) is an online education holding company based in Phoenix, Arizona. It operates two institutions — Aspen University (AU) and United States University (USU) — focused primarily on online nursing and healthcare degrees. As of its latest filings, approximately 84% of all active students are degree-seeking nursing students, positioning the company squarely inside one of the most structurally undersupplied professions in America.

This is not a flashy AI play. It is not a hype stock. It is a small, largely overlooked company that spent two painful years getting its house in order — and now, quietly, the numbers are starting to tell a different story.

For Q3 Fiscal Year 2026 (ended January 31, 2026), Aspen Group reported:

That is now three consecutive quarters of net income. For a company that was hemorrhaging cash just 18 months ago, that is a meaningful inflection point.

Revenue came in at $10.4 million, down 5% year-over-year — so top-line growth is still a work in progress. But the margin story is real, and it is accelerating.

The turnaround was not accidental. Aspen executed five restructuring rounds over the past two fiscal years, systematically eliminating cost. The most recent restructuring, implemented in September 2025, eliminated approximately 75 positions and is expected to deliver roughly $1.5 million in additional quarterly G&A savings beginning in Q3 FY2026.

Management also made a deliberate decision to hold marketing spend at maintenance levels while the cost base was being rebuilt. The tradeoff is visible: new student enrollments are down significantly year-over-year. But with the savings locked in, the company has now signaled it will resume marketing investment to drive enrollment growth — a potential top-line catalyst for fiscal year 2027.

In March 2026, Aspen announced a planned CEO succession. Matt LaVay, who has served as CFO since 2021 and is credited as the architect of the restructuring, was appointed Chief Executive Officer. Founder Michael Mathews, who has led the company since 2012, moves to Executive Chairman and remains full-time.

The signal here matters. This is not a distress-driven leadership change — it is the company handing the wheel to the operator who built the new cost structure and guided it to profitability. LaVay knows where every dollar is.

In September 2025, Aspen announced plans to merge Aspen University and United States University into a single institution, with USU as the surviving entity. The rationale: combining resources, reducing operational duplication, and strengthening long-term accreditation positioning.

Accreditation is not a small detail. Aspen University received a five-year reaccreditation from DEAC through January 2029 — the maximum period allowed — which removes a significant overhang that spooked investors in prior years. USU's revenue grew 9% year-over-year in the most recent quarter, making it the stronger of the two brands to carry forward.

ASPU trades on the OTCQB Venture Market with a market cap of approximately $7–9 million as of late April 2026. The 52-week range spans from roughly $0.045 to $0.30 — this is a penny stock, and it trades like one.

The stock has risen over 100% in the past 12 months and approximately 67% in the past month alone, largely driven by the Q3 earnings beat. Volume is thin. Liquidity is low. Price swings are common.

One near-term concern: the company carries approximately $5.8 million in debt maturing in May 2026. Management has stated it is actively exploring refinancing options. How that resolves will be a key catalyst — or headwind — in the coming weeks.

Online nursing education is not going away. The U.S. nursing shortage is structural, not cyclical, and demand for accessible, affordable online degree programs in healthcare is durable. Aspen and USU serve a population of working adults — largely women, largely already employed in healthcare — who need flexible, accredited pathways to advance their credentials.

If the company can stabilize enrollments and begin growing again while maintaining its new cost discipline, the earnings leverage could be significant at this valuation. A $7 million market cap on a company generating $3 million in quarterly EBITDA is a striking ratio — if the trajectory holds.

That is a big if. OTC-listed micro-caps carry risks that are real and numerous: thin trading, limited analyst coverage, refinancing risk, enrollment headwinds, and regulatory exposure. None of that goes away because the margin line improved.

ASPU is not for everyone. It is a high-risk, low-liquidity OTC stock with a complicated recent history and a long road back to relevance at scale. But the operational story is genuinely improving — and almost no one is paying attention yet.

Three profitable quarters. A 73% gross margin. A new CEO who built the restructuring from scratch. A merger that could simplify the business. And a market cap that still reflects the darkest days of 2024.

Worth watching.

— Watchlist Ventures

⚠️ Disclaimer: This newsletter is for informational and educational purposes only. It does not constitute financial, investment, or legal advice. Nothing in this newsletter should be construed as a recommendation to buy, sell, or hold any security. ASPU is a speculative micro-cap stock traded on the OTC markets. OTC securities are subject to significant risks including limited liquidity, high volatility, limited regulatory oversight, and the potential for total loss of investment. Always conduct your own due diligence and consult a licensed financial advisor before making any investment decisions. The author and Watchlist Ventures may or may not hold positions in securities mentioned. Past performance is not indicative of future results.